Satz P, Hynd G W, D'Elia L, Daniel M H, Van Gorp W, Connor R
Neuropsychiatric Institute, University of California, Los Angeles 90024.
J Clin Exp Neuropsychol. 1990 Oct;12(5):759-65. doi: 10.1080/01688639008401017.
Recent reports have provided evidence that a WAIS-R marker for dementia of the Alzheimer's type (DAT) may have value in differential clinical diagnosis. Using the Fuld (1984) formula, this study investigated the prevalence of the WAIS-R marker in the WAIS-R standardization sample (N = 1,880), whose members range in age from 16 to 74 years. The results from the WAIS-R sample suggest no significant age differences in the occurrence of this marker when age-corrected scaled scores are employed. Across age, the occurrence of this marker is about 6.2%. Although there were no significant effects according to race, there were significant sex (males = 7.34%; females = 5.11%) and education effects. For individuals aged 65-74 with some post high school education, the base rate was about 14%. These findings are discussed as they relate to the potential clinical usefulness of this marker in the differential diagnosis of DAT.
最近的报告提供了证据,表明韦氏成人智力量表修订版(WAIS-R)中阿尔茨海默病型痴呆(DAT)的一个指标可能在临床鉴别诊断中具有价值。本研究使用富尔德(1984年)的公式,调查了WAIS-R标准化样本(N = 1880)中该WAIS-R指标的患病率,样本成员年龄在16至74岁之间。WAIS-R样本的结果表明,当使用年龄校正后的量表分数时,该指标的出现没有显著的年龄差异。在所有年龄段中,该指标的出现率约为6.2%。虽然按种族没有显著影响,但存在显著的性别(男性 = 7.34%;女性 = 5.11%)和教育程度影响。对于65至74岁且有高中后某种教育程度的个体,基础率约为14%。讨论了这些发现与该指标在DAT鉴别诊断中的潜在临床实用性的关系。